Posts
News
NEWS
PRESS RELEASES
AFNET terminates NOAH – AFNET 6 trial ahead of time
The NOAH – AFNET 6 trial which is conducted to evaluate the potential benefit of…
Attaining sinus rhythm mediates improved outcomes with early rhythm control therapy of atrial fibrillation
A mediator analysis of the EAST – AFNET 4 trial dataset revealed the key factor…
Subanalysis of the EAST – AFNET 4 trial: Patients with AF and high comorbidity burden benefit from early rhythm control
Posts NEWS Fri, 29.04.2022 Subanalysis of the EAST – AFNET 4 trial: Patients with AF…
EAST – AFNET 4 trial: Patients with first diagnosed atrial fibrillation (AF) benefit from early rhythm control
Early rhythm control is useful in patients with atrial fibrillation regardless of the AF pattern….
Early rhythm control improves outcomes in patients with asymptomatic atrial fibrillation
Asymptomatic patients with atrial fibrillation (AF) benefit from early rhythm control therapy comparably to symptomatic…
Patients with atrial fibrillation and heart failure benefit from early rhythm control
A subgroup analysis of the EAST – AFNET 4 study population revealed: Early initiation of…
RESULTS: EAST-AFNET 4
Patients with newly diagnosed atrial fibrillation (AF) benefit from early rhythm control therapy, according to…